Kyle Jenne, EVP, Chf GL Pdt Str Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 58,468 shares at $75.50 ($4.4M) on 2026-03-10, disclosed to the SEC on 2026-03-11.
Open-market sale of $4.4M IONS by EVP, Chf GL Pdt Str Ofcr. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.50 | 21,191 | $1.6M | 36.1% |
| 2 | $75.50 | 21,191 | $1.6M | 36.1% |
| 3 | $76.30 | 16,086 | $1.2M | 27.7% |
| Total | $75.72 avg | 58,468 | $4.4M | 100% |
| Filing → |
| IONS | SELL | 2025-04-17 | $171K | — | Filing → |
| AKCA | SELL | 2020-09-24 | $13K | — | Filing → |
| AKCA | SELL | 2020-03-25 | $9K | — | Filing → |